antineoplastisch middel	Colony stimulating factor 1 receptor antagonist	Organic cation transporter 2 inhibitor	Protein-tyrosine kinase inhibitor	Pyrimidine and/or pyrimidine derivative
\|	\|	\|	\|	\|

Vimseltinib (substance)
	Vimseltinib

Id	1396132001
Status	Primitive

Has disposition	Colony stimulating factor 1 receptor antagonist
Has disposition	Organic cation transporter 2 inhibitor
Has disposition	proteïnetyrosinekinaseremmer